Literature DB >> 17597456

Maternal antibody and viral factors in the pathogenesis of dengue virus in infants.

Cameron P Simmons1, Tran Nguyen Bich Chau, Tran Thi Thuy, Nguyen Minh Tuan, Dang Minh Hoang, Nguyen Thanh Thien, Le Bich Lien, Nguyen Thien Quy, Nguyen Trong Hieu, Tran Tinh Hien, Catriona McElnea, Paul Young, Steve Whitehead, Nguyen Thanh Hung, Jeremy Farrar.   

Abstract

The pathogenesis of dengue in infants is poorly understood. We postulated that dengue severity in infants would be positively associated with markers of viral burden and that maternally derived, neutralizing anti-dengue antibody would have decayed before the age at which infants with dengue presented to the hospital. In 75 Vietnamese infants with primary dengue, we found significant heterogeneity in viremia and NS1 antigenemia at hospital presentation, and these factors were independent of disease grade or continuous measures of disease severity. Neutralizing antibody titers, predicted in each infant at the time of their illness, suggested that the majority of infants (65%) experienced dengue hemorrhagic fever when the maternally derived neutralizing antibody titer had declined to <1 : 20. Collectively, these data have important implications for dengue vaccine research because they suggest that viral burden may not solely explain severe dengue in infants and that neutralizing antibody is a reasonable but not absolute marker of protective immunity in infants.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17597456      PMCID: PMC4333207          DOI: 10.1086/519170

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  21 in total

Review 1.  Dengue: an update.

Authors:  María G Guzmán; Gustavo Kourí
Journal:  Lancet Infect Dis       Date:  2002-01       Impact factor: 25.071

2.  A prospective study of dengue infections in Bangkok.

Authors:  D S Burke; A Nisalak; D E Johnson; R M Scott
Journal:  Am J Trop Med Hyg       Date:  1988-01       Impact factor: 2.345

3.  Risk factors in dengue shock syndrome.

Authors:  S Thein; M M Aung; T N Shwe; M Aye; A Zaw; K Aye; K M Aye; J Aaskov
Journal:  Am J Trop Med Hyg       Date:  1997-05       Impact factor: 2.345

4.  Dengue Virus (DV) enhancing antibody activity in preillness plasma does not predict subsequent disease severity or viremia in secondary DV infection.

Authors:  Kamolwish Laoprasopwattana; Daniel H Libraty; Timothy P Endy; Ananda Nisalak; Supamit Chunsuttiwat; David W Vaughn; George Reed; Francis A Ennis; Alan L Rothman; Sharone Green
Journal:  J Infect Dis       Date:  2005-07-05       Impact factor: 5.226

5.  A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. studies in 1995-1996.

Authors:  R R Graham; M Juffrie; R Tan; C G Hayes; I Laksono; C Ma'roef; K R Porter; S B Halstead
Journal:  Am J Trop Med Hyg       Date:  1999-09       Impact factor: 2.345

6.  Transplacentally transferred maternal-infant antibodies to dengue virus.

Authors:  Veerachai Watanaveeradej; Timothy P Endy; Rudiwilai Samakoses; Angkool Kerdpanich; Sriluck Simasathien; Napuschon Polprasert; Chanchai Aree; David W Vaughn; Cynthia Ho; Ananda Nisalak
Journal:  Am J Trop Med Hyg       Date:  2003-08       Impact factor: 2.345

7.  Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand.

Authors:  Timothy P Endy; Ananda Nisalak; Supamit Chunsuttitwat; David W Vaughn; Sharone Green; Francis A Ennis; Alan L Rothman; Daniel H Libraty
Journal:  J Infect Dis       Date:  2004-03-01       Impact factor: 5.226

8.  High circulating levels of the dengue virus nonstructural protein NS1 early in dengue illness correlate with the development of dengue hemorrhagic fever.

Authors:  Daniel H Libraty; Paul R Young; Darren Pickering; Timothy P Endy; Siripen Kalayanarooj; Sharone Green; David W Vaughn; Ananda Nisalak; Francis A Ennis; Alan L Rothman
Journal:  J Infect Dis       Date:  2002-09-16       Impact factor: 5.226

Review 9.  Dengue: the risk to developed and developing countries.

Authors:  T P Monath
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-29       Impact factor: 11.205

10.  Antibodies against prM protein distinguish between previous infection with dengue and Japanese encephalitis viruses.

Authors:  Mary Jane Cardosa; Seok Mui Wang; Magdline Sia H Sum; Phaik Hooi Tio
Journal:  BMC Microbiol       Date:  2002-05-05       Impact factor: 3.605

View more
  78 in total

Review 1.  Dengue vaccine trial guidelines and role of large-scale, post proof-of-concept demonstration projects in bringing a dengue vaccine to use in dengue endemic areas.

Authors:  G William Letson; Pratap Singhasivanon; Eduardo Fernandez; Nihal Abeysinghe; Juan Jose Amador; Harold S Margolis; Robert Edelman
Journal:  Hum Vaccin       Date:  2010-10-01

2.  Neutralizing antibody titers against dengue virus correlate with protection from symptomatic infection in a longitudinal cohort.

Authors:  Leah C Katzelnick; Magelda Montoya; Lionel Gresh; Angel Balmaseda; Eva Harris
Journal:  Proc Natl Acad Sci U S A       Date:  2016-01-04       Impact factor: 11.205

Review 3.  How innate immune mechanisms contribute to antibody-enhanced viral infections.

Authors:  Sukathida Ubol; Scott B Halstead
Journal:  Clin Vaccine Immunol       Date:  2010-09-28

4.  Dengue: where are we today?

Authors:  Maria Guadalupe Guzman; Susana Vázquez; Gustavo Kouri
Journal:  Malays J Med Sci       Date:  2009-07

Review 5.  Biochemistry and Molecular Biology of Flaviviruses.

Authors:  Nicholas J Barrows; Rafael K Campos; Kuo-Chieh Liao; K Reddisiva Prasanth; Ruben Soto-Acosta; Shih-Chia Yeh; Geraldine Schott-Lerner; Julien Pompon; October M Sessions; Shelton S Bradrick; Mariano A Garcia-Blanco
Journal:  Chem Rev       Date:  2018-04-13       Impact factor: 60.622

6.  Placental Transfer of Dengue Virus (DENV)-Specific Antibodies and Kinetics of DENV Infection-Enhancing Activity in Brazilian Infants.

Authors:  Priscila M S Castanha; Cynthia Braga; Marli T Cordeiro; Ariani I Souza; Claudeir D Silva; Celina M T Martelli; Willem G van Panhuis; Eduardo J M Nascimento; Ernesto T A Marques
Journal:  J Infect Dis       Date:  2016-04-07       Impact factor: 5.226

7.  Decay and persistence of maternal dengue antibodies among infants in Bangkok.

Authors:  Willem G van Panhuis; Christine Luxemburger; Krisana Pengsaa; Kriengsak Limkittikul; Arunee Sabchareon; Jean Lang; Anna P Durbin; Derek A T Cummings
Journal:  Am J Trop Med Hyg       Date:  2011-08       Impact factor: 2.345

8.  Leukocyte immunoglobulin-like receptor B1 is critical for antibody-dependent dengue.

Authors:  Kuan Rong Chan; Eugenia Z Ong; Hwee Cheng Tan; Summer Li-Xin Zhang; Qian Zhang; Kin Fai Tang; Nivashini Kaliaperumal; Angeline Pei Chiew Lim; Martin L Hibberd; Soh Ha Chan; John E Connolly; Manoj N Krishnan; Shee Mei Lok; Brendon J Hanson; Chao-Nan Lin; Eng Eong Ooi
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

9.  Clinical and virological features of Dengue in Vietnamese infants.

Authors:  Tran Nguyen Bich Chau; Katherine L Anders; Le Bich Lien; Nguyen Thanh Hung; Lu Thi Minh Hieu; Nguyen Minh Tuan; Tran Thi Thuy; Le Thi Phuong; Nguyen Thi Hong Tham; Mai Ngoc Lanh; Jeremy J Farrar; Stephen S Whitehead; Cameron P Simmons
Journal:  PLoS Negl Trop Dis       Date:  2010-04-13

10.  A prospective nested case-control study of Dengue in infants: rethinking and refining the antibody-dependent enhancement dengue hemorrhagic fever model.

Authors:  Daniel H Libraty; Luz P Acosta; Veronica Tallo; Edelwisa Segubre-Mercado; Analisa Bautista; James A Potts; Richard G Jarman; In-Kyu Yoon; Robert V Gibbons; Job D Brion; Rosario Z Capeding
Journal:  PLoS Med       Date:  2009-10-27       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.